21st Austria weekly - Warimpex 29/11/2023 [pic1]Warimpex: Real estate company Group succeeded in generating a clearly positive result amidst the still challenging market conditions first three quarters of year. Operating business remained strong with 16 per cent increase revenue and 5 improvement EBITDA. After depreciation amortisation property valuations this resulted profit for period EUR 3.2 million down from 13.6 million prior-year period. The focus recent activities has been on successful adoption new zoning plan office commercial developments Darmstadt as well completion Mogilska 35 Office Krakow after reporting date. “Our long-standing strategy allows us to retain necessary flexibility long-term stability – even excel at getting real projects off ground successfully implementing them ” commented CEO Franz
Wie Gurktaler AG Stamm Cleen Energy Stadlauer Malzfabrik AG AMS Warimpex und Semperit für Gesprächsstoff in Österreich sorgten Aktie Symbol SK Perf. Stamm GAGS 18 5.88% Energy CLEN 4 4.71% SEM 20.95 2.95% WXF 0.81 -3.57% AMS
Week 23 was a good week for ATX TR, which gained 1,66 percent to 6945 points. The best performers came from the 2nd row: Kapsch TrafficCom, Warimpex and Frequentis. News came from CA Immo, EVN, S Immo
21st Austria weekly - Valneva Warimpex RHI Magnesita 30/05/2023 [pic1]Valneva: Valneva. an Austrian/French specialty vaccine company today announces the filing of a regulatory application with Health Canada for marketing approval Company’s single-shot chikungunya candidate VLA1553 in persons aged 18 years and above. This is second VLA1553 filed by Company intends to make additional submissions 2023.Valneva: performance: -3.30% Warimpex: The business operations Warimpex Group